Patricia M. McGowan

3.0k total citations
33 papers, 2.3k citations indexed

About

Patricia M. McGowan is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Patricia M. McGowan has authored 33 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Cancer Research. Recurrent topics in Patricia M. McGowan's work include HER2/EGFR in Cancer Research (18 papers), Peptidase Inhibition and Analysis (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Patricia M. McGowan is often cited by papers focused on HER2/EGFR in Cancer Research (18 papers), Peptidase Inhibition and Analysis (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Patricia M. McGowan collaborates with scholars based in Ireland, United States and United Kingdom. Patricia M. McGowan's co-authors include Michael J. Duffy, John Crown, Norma O’Donovan, William M. Gallagher, MJ Duffy, Maeve Mullooly, Eadaoin McKiernan, Naoise C. Synnott, Christoph Thomssen and Nadia Harbeck and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Patricia M. McGowan

33 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia M. McGowan Ireland 22 1.3k 1.1k 682 337 294 33 2.3k
Dorina Belotti Italy 26 897 0.7× 1.3k 1.1× 779 1.1× 264 0.8× 220 0.7× 43 2.4k
R. Daniel Bonfil United States 30 1.3k 1.0× 1.1k 1.0× 925 1.4× 296 0.9× 473 1.6× 78 2.6k
Simonetta Buglioni Italy 22 772 0.6× 930 0.8× 511 0.7× 176 0.5× 227 0.8× 71 1.7k
Patrizia Borsotti Italy 26 868 0.7× 1.7k 1.5× 1.0k 1.5× 207 0.6× 266 0.9× 33 2.9k
Helmout Modjtahedi United Kingdom 30 1.4k 1.1× 1.1k 0.9× 333 0.5× 129 0.4× 548 1.9× 81 2.5k
Minji Jo United States 23 796 0.6× 1.6k 1.4× 902 1.3× 243 0.7× 203 0.7× 33 2.5k
Angela Garofalo Italy 23 807 0.6× 985 0.9× 687 1.0× 437 1.3× 137 0.5× 35 2.0k
Tiziana Triulzi Italy 30 1.4k 1.1× 1.7k 1.5× 1.2k 1.7× 137 0.4× 345 1.2× 61 3.3k
Jordi Codony‐Servat Spain 22 1.5k 1.2× 1.2k 1.1× 553 0.8× 129 0.4× 665 2.3× 56 2.5k
Scott A. Boerner United States 23 852 0.7× 1.2k 1.1× 334 0.5× 154 0.5× 337 1.1× 40 2.2k

Countries citing papers authored by Patricia M. McGowan

Since Specialization
Citations

This map shows the geographic impact of Patricia M. McGowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia M. McGowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia M. McGowan more than expected).

Fields of papers citing papers by Patricia M. McGowan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia M. McGowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia M. McGowan. The network helps show where Patricia M. McGowan may publish in the future.

Co-authorship network of co-authors of Patricia M. McGowan

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia M. McGowan. A scholar is included among the top collaborators of Patricia M. McGowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia M. McGowan. Patricia M. McGowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramos-Martín, V., Michael Neely, Patricia M. McGowan, et al.. (2016). Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy. Journal of Antimicrobial Chemotherapy. 71(11). 3168–3178. 22 indexed citations
2.
Mullooly, Maeve, Patricia M. McGowan, John Crown, & Michael J. Duffy. (2016). The ADAMs family of proteases as targets for the treatment of cancer. Cancer Biology & Therapy. 17(8). 870–880. 87 indexed citations
3.
Hague, M. Nicole, et al.. (2016). Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis. Journal of Molecular Medicine. 94(8). 899–910. 9 indexed citations
4.
Caiazza, Francesco, Patricia M. McGowan, Maeve Mullooly, et al.. (2015). Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells. British Journal of Cancer. 112(12). 1895–1903. 47 indexed citations
5.
Mullooly, Maeve, Dylan Conklin, Patricia M. McGowan, et al.. (2015). Neratinib to inhibit the growth of triple-negative breast cancer cells.. Journal of Clinical Oncology. 33(15_suppl). 1099–1099. 8 indexed citations
6.
Synnott, Naoise C., Patricia M. McGowan, Maeve Kiely, et al.. (2015). PRIMA-1MET (APR-246): A novel targeted therapy for triple negative breast cancer?. Journal of Clinical Oncology. 33(15_suppl). e12072–e12072. 1 indexed citations
7.
Duffy, Michael J., Patricia M. McGowan, Nadia Harbeck, Christoph Thomssen, & Manfred Schmitt. (2014). uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Research. 16(4). 428–428. 197 indexed citations
8.
Synnott, Naoise C., Maeve Mullooly, Francesco Caiazza, et al.. (2014). Mutant p53: A therapeutic target for the treatment of triple-negative breast cancer?. Journal of Clinical Oncology. 32(15_suppl). 1118–1118. 1 indexed citations
9.
Canonici, Alexandra, Merel Gijsen, Maeve Mullooly, et al.. (2013). Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer. Oncotarget. 4(10). 1592–1605. 137 indexed citations
10.
McGowan, Patricia M., Maura B. Cotter, Maeve Mullooly, et al.. (2013). Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines. Cancer Biology & Therapy. 14(6). 537–545. 30 indexed citations
11.
Romagnoli, Mathilde, Nora D. Mineva, Michael Polmear, et al.. (2013). ADAM 8 expression in invasive breast cancer promotes tumor dissemination and metastasis. EMBO Molecular Medicine. 6(2). 278–294. 80 indexed citations
12.
Duffy, Michael J., Patricia M. McGowan, & John Crown. (2012). Targeted therapy for triple‐negative breast cancer: Where are we?. International Journal of Cancer. 131(11). 2471–2477. 80 indexed citations
13.
McGowan, Patricia M., Maeve Mullooly, Francesco Caiazza, et al.. (2012). ADAM-17: a novel therapeutic target for triple negative breast cancer. Annals of Oncology. 24(2). 362–369. 46 indexed citations
14.
McGowan, Patricia M., Emeline J. Ribot, Paula J. Foster, et al.. (2011). Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer. Molecular Cancer Research. 9(7). 834–844. 116 indexed citations
15.
Duffy, Michael J., et al.. (2011). The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?. Clinical Proteomics. 8(1). 9–9. 163 indexed citations
16.
Duffy, Michael J., Eadaoin McKiernan, Norma O’Donovan, & Patricia M. McGowan. (2009). The role of ADAMs in disease pathophysiology. Clinica Chimica Acta. 403(1-2). 31–36. 56 indexed citations
17.
McGowan, Patricia M., et al.. (2009). Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches. Future Oncology. 5(7). 1083–1098. 35 indexed citations
18.
McGowan, Patricia M., Eadaoin McKiernan, Ferdia Bolster, et al.. (2008). ADAM-17 predicts adverse outcome in patients with breast cancer. Annals of Oncology. 19(6). 1075–1081. 68 indexed citations
19.
McGowan, Patricia M. & Michael J. Duffy. (2008). Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. Annals of Oncology. 19(9). 1566–1572. 127 indexed citations
20.
Duffy, MJ, Patricia M. McGowan, & William M. Gallagher. (2007). Cancer invasion and metastasis: changing views. The Journal of Pathology. 214(3). 283–293. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorina Belotti Breakdown of academic impact, for papers by R. Daniel Bonfil Breakdown of academic impact, for papers by Simonetta Buglioni Breakdown of academic impact, for papers by Patrizia Borsotti Breakdown of academic impact, for papers by Helmout Modjtahedi Breakdown of academic impact, for papers by Minji Jo Breakdown of academic impact, for papers by Angela Garofalo Breakdown of academic impact, for papers by Tiziana Triulzi Breakdown of academic impact, for papers by Jordi Codony‐Servat Breakdown of academic impact, for papers by Scott A. Boerner
Rankless by CCL
2026